Takeo Kosaka

60PUBLICATIONS
58CO-AUTHORS
Molecular targetsCancer diagnosisNeurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (60)

|Jan 30, 2026
Drastic Response to Olaparib in a Patient With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA2 Alterations and Near-Threshold Tumor Mutational Burden.

Kotaro Yokota, Takeo Kosaka, Tatsuaki Daimon

|Dec 31, 2025
Incidentally Detected Ductal Adenocarcinoma Presenting With Isolated Pulmonary Metastasis and a BRCA2 Mutation.

Hiroyuki Karasawa, Takeo Kosaka, Akari Komatsuda

|Jul 21, 2025
Safety and Efficacy of Tarlatamab in Patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study.

Rahul Aggarwal, Sylvie Rottey, Alice Bernard-Tessier

|Mar 04, 2025
A case of testicular dysgenesis syndrome with squamous cell carcinoma of the prostate harboring a CDK12 mutation.

Yasuaki Murata, Takeo Kosaka, Kohei Nakamura

|Dec 31, 2024
Phase 3 Study of Talazoparib Plus Enzalutamide Versus Placebo Plus Enzalutamide as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer: TALAPRO-2 Japanese Subgroup Analysis.

Nobuaki Matsubara, Hideaki Miyake, Hiroji Uemura

|Nov 24, 2024
Dynamics in the Prostate Immune Microenvironment Induced by Androgen Deprivation Therapy.

Yoshinori Yanai, Takeo Kosaka, Shuji Mikami

Pageof 10

Frequent Collaborators

9 joint publications

Kazuhiro Matsumoto

6 joint publications

Mototsugu Oya

4 joint publications

Shuji Mikami

3 joint publications

Eiji Kikuchi